Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 4
2017 4
2018 3
2019 2
2020 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase).
Boveda S, Garcia R, Defaye P, Piot O, Narayanan K, Barra S, Gras D, Providencia R, Algalarrondo V, Beganton F, Perier MC, Jacob S, Bordachar P, Babuty D, Klug D, Leclercq C, Fauchier L, Sadoul N, Deharo JC, Marijon E; DAI-PP investigators. Boveda S, et al. Arch Cardiovasc Dis. 2019 Aug-Sep;112(8-9):523-531. doi: 10.1016/j.acvd.2019.05.005. Epub 2019 Aug 27. Arch Cardiovasc Dis. 2019. PMID: 31471226 Free article. Review.
Early mortality after implantable cardioverter defibrillator: Incidence and associated factors.
Garcia R, Boveda S, Defaye P, Sadoul N, Narayanan K, Perier MC, Klug D, Fauchier L, Leclercq C, Babuty D, Bordachar P, Gras D, Deharo JC, Piot O, Providencia R, Marijon E, Algalarrondo V; DAI-PP Investigators. Garcia R, et al. Int J Cardiol. 2020 Feb 15;301:114-118. doi: 10.1016/j.ijcard.2019.09.033. Epub 2019 Oct 30. Int J Cardiol. 2020. PMID: 31753583
Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention.
Ascoeta MS, Marijon E, Defaye P, Klug D, Beganton F, Perier MC, Gras D, Algalarrondo V, Deharo JC, Leclercq C, Fauchier L, Babuty D, Bordachar P, Sadoul N, Boveda S, Piot O; DAI-PP Investigators. Ascoeta MS, et al. Heart Rhythm. 2016 May;13(5):1045-1051. doi: 10.1016/j.hrthm.2015.12.046. Epub 2016 Jan 1. Heart Rhythm. 2016. PMID: 26749313 Free article.
Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
Algalarrondo V, Perault R, Bories MC, Narayanan K, Garcia R, Combes N, Perier MC, Defaye P, Sadoul N, Gras D, Klug D, Bordachar P, Fauchier L, Deharo JC, Leclercq C, Boveda S, Marijon E, Babuty D; DAI-PP investigators. Algalarrondo V, et al. Arch Cardiovasc Dis. 2018 Dec;111(12):758-765. doi: 10.1016/j.acvd.2018.05.004. Epub 2018 Aug 2. Arch Cardiovasc Dis. 2018. PMID: 30078651 Free article.
Usefulness of a clinical risk score to predict the response to cardiac resynchronization therapy.
Providencia R, Marijon E, Barra S, Reitan C, Breitenstein A, Defaye P, Papageorgiou N, Duehmke R, Winnik S, Ang R, Klug D, Gras D, Oezkartal T, Segal OR, Deharo JC, Leclercq C, Lambiase PD, Fauchier L, Bordachar P, Steffel J, Sadoul N, Piot O, Borgquist R, Agarwal S, Chow A, Boveda S; DAI-PP Investigators. Providencia R, et al. Int J Cardiol. 2018 Jun 1;260:82-87. doi: 10.1016/j.ijcard.2018.02.012. Int J Cardiol. 2018. PMID: 29622458 Free article.
Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification.
Providência R, Boveda S, Defaye P, Segal O, Algalarrondo V, Sadoul N, Lambiase P, Piot O, Klug D, Perier MC, Bouzeman A, Barra S, Bories MC, Gras D, Fauchier L, Bordachar P, Babuty D, Deharo JC, Leclercq C, Marijon E; DAI-PP Investigators. Providência R, et al. Am J Cardiol. 2016 Oct 15;118(8):1225-1232. doi: 10.1016/j.amjcard.2016.07.037. Epub 2016 Jul 29. Am J Cardiol. 2016. PMID: 27561197
Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
Amara N, Boveda S, Defaye P, Klug D, Treguer F, Amet D, Perier MC, Gras D, Algalarrondo V, Bouzeman A, Piot O, Deharo JC, Fauchier L, Babuty D, Bordachar P, Sadoul N, Marijon E, Leclercq C; DAI-PP Investigators. Amara N, et al. Europace. 2018 Jan 1;20(1):65-72. doi: 10.1093/europace/euw379. Europace. 2018. PMID: 28082419
Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study.
Clementy N, Challal F, Marijon E, Boveda S, Defaye P, Leclercq C, Deharo JC, Sadoul N, Klug D, Piot O, Gras D, Bordachar P, Algalarrondo V, Fauchier L, Babuty D; DAI-PP Investigators. Clementy N, et al. Heart Rhythm. 2017 Feb;14(2):211-217. doi: 10.1016/j.hrthm.2016.10.024. Epub 2016 Oct 28. Heart Rhythm. 2017. PMID: 27989789
Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable-Prévention Primaire registry.
Defaye P, Boveda S, Klug D, Beganton F, Piot O, Narayanan K, Périer MC, Gras D, Fauchier L, Bordachar P, Algalarrondo V, Babuty D, Deharo JC, Leclercq C, Marijon E, Sadoul N; DAI-PP Investigators. Defaye P, et al. Europace. 2017 Sep 1;19(9):1478-1484. doi: 10.1093/europace/euw230. Europace. 2017. PMID: 28340096
14 results